All News

The 12 groups represent practice settings of nearly all pharmacists in the United States.

“We’re pretty devastated,” said Jessica Harris, a friend of Rutter, in an interview with WFSB. “She beat cancer and lost the battle to coronavirus—it’s just crazy.”

More than 90% of physicians, nurses, and pharmacists are concerned about COVID-19 affecting their patients, whereas 68% of doctors and 67% of nurses feel they are reasonably prepared for a COVID-19 outbreak in their area.

Four out of 8 manufacturers of hydroxychloroquine, an anti-malarial drug that had shown some success treating the symptoms of the novel coronavirus (COVID-19), are already experiencing shortages.

A new report from the CDC has found that a significant portion of hospitalizations in the United States have come from younger adults.

The study focused on whether moderate alcohol intake is related to reductions in amyloid-beta deposition or is protective via amyloid-independent mechanisms in the living human brain since little information was available.

The FDA has released a statement addressing the issue, stating that the organization is “not aware of scientific evidence connecting the use of NSAIDs, like ibuprofen, with worsening COVID-19 symptoms.”

CVS mistakenly sent unproven information to employees surrounding drinking warm water to combat the novel coronavirus.

All 3 trials reached their primary endpoints, specifically percentage change in low-density lipoprotein cholesterol (LDL-C) from baseline to 17 months and time-adjusted percentage change in LDL-C from baseline from 3 to 18 months.

As the COVID-19 pandemic continues, a key issue for pharmacists, other health care professionals, and patients is the potential for disruptions in the US medication supply chain.

Top news of the week from Pharmacy Times surrounding the novel coronavirus.

The drug was previously approved to treat HCV in adults

The General Pharmaceutical Council has made plans to temporarily re-register pharmacists and pharmacy technicians should the government launch a state of emergency due to the novel coronavirus.

Researchers in Australia tested blood samples at 4 different time points in an otherwise healthy adult woman who presented with COVID-19 and had mild-to-moderate symptoms requiring hospital admission.

This will be the first global study of tocilizumab in this setting and is expected to begin enrolling in early April, with a target of approximately 330 patients globally.

Chloroquine and remdesivir are not FDA-approved for a COVID-19 indications.

Although preventive measures may be largely the same for patients with cancer during the COVID-19, the pandemic could result in difficult treatment decisions.

Members of AHIP will take steps to ensure affordable access to COVID-19 testing and treatment, according to a statement from the company.

With the publication of the new vancomycin guidelines, pharmacists are going to experience a major change from trough-based monitoring of vancomycin to area under the curve-based dosing strategies.

Earlier this week, the FDA updated its guidance on testing for the novel coronavirus (COVID-19), allowing clinical laboratories to create and perform COVID-19 tests without pursuing FDA emergency use authorization (EUA).

Now is the time for pharmacists to stand even taller and provide more help to their communities.

Furthermore, they established that 101 out of every 10,000 cases will develop symptoms after 14 days of active monitoring or quarantine.

The researchers found that the average yearly out-of-pocket spending by patients with diabetes is over $1,800.

The American Pharmacists Association (APhA) is calling upon the federal Coronavirus Task Force to make greater use of pharmacists in combating the novel coronavirus (COVID-19) outbreak.

SARS-CoV-2 was detectable in aerosols for up to 3 hours, up to 4 hours on copper, up to 24 hours on cardboard, and up to 3 days on plastic and stainless steel.

The availability of personal protective equipment, including face masks, gloves and hand sanitizers, have been a concern to many pharmacists.

Value-added pharmacy services come in all shapes and sizes.

Pharmacy giants Walgreens and CVS are taking extensive steps to ensure patient access to medications during the novel coronavirus (COVID-19) pandemic, including waiving drug delivery fees and expanding telehealth options.